CAI
Caris Life Sciences, Inc.Company with tickers: CAI
Market Cap
$5.35B
Shares Outstanding
282,680,695
CIK
2019410
CUSIP
142152107
13F Activity (30d)
1 filings
1 filers
Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this stock, matched by the stock's CUSIP. Each row is one fund position with its size, value and weight in that fund.
Funds holding CAI
216 fund positions| Fund | Ticker | Balance | Value | % of Fund | Side | Reported | Open |
|---|---|---|---|---|---|---|---|
| Select Health Care Portfolio | — | 3,050,000 | $61,427,000 | 0.99% | Long | 2026-02-28 | |
| VANGUARD TOTAL STOCK MARKET INDEX FUND | — | 3,155,698 | $56,423,880 | 0.00% | Long | 2026-03-31 | |
| Select Medical Technology and Devices Portfolio | — | 2,700,000 | $54,378,000 | 1.49% | Long | 2026-02-28 | |
| T. Rowe Price Mid-Cap Growth Fund, Inc. | — | 2,704,204 | $48,351,168 | 0.21% | Long | 2026-03-31 | |
| VIP Mid Cap Portfolio | — | 2,693,500 | $48,159,780 | 0.60% | Long | 2026-03-31 | |
| Strategic Advisers Fidelity U.S. Total Stock Fund | — | 2,139,300 | $43,085,502 | 0.02% | Long | 2026-02-28 | |
| Fidelity Contrafund | — | 2,332,471 | $41,704,581 | 0.03% | Long | 2026-03-31 | |
| VANGUARD SMALL-CAP INDEX FUND | — | 2,274,539 | $40,668,757 | 0.02% | Long | 2026-03-31 | |
| T. Rowe Price Health Sciences Fund, Inc. | — | 1,909,867 | $34,148,422 | 0.31% | Long | 2026-03-31 | |
| JPMorgan Mid Cap Growth Fund | — | 1,691,144 | $30,237,655 | 0.27% | Long | 2026-03-31 | |
| Fidelity Puritan Fund | — | 1,242,900 | $25,032,006 | 0.08% | Long | 2026-02-28 | |
| Fidelity Growth Company Fund | — | 1,235,594 | $24,884,863 | 0.03% | Long | 2026-02-28 | |
| VANGUARD SMALL-CAP GROWTH INDEX FUND | — | 1,273,266 | $22,765,996 | 0.06% | Long | 2026-03-31 | |
| Fidelity U.S. Equity Central Fund | — | 1,200,000 | $21,456,000 | 0.11% | Long | 2026-03-31 | |
| SMALLCAP World Fund Inc | — | 1,180,173 | $21,101,493 | 0.03% | Long | 2026-03-31 | |
| Invesco Discovery Fund | — | 803,618 | $16,184,867 | 0.24% | Long | 2026-02-28 | |
| iShares Biotechnology ETF | — | 898,011 | $16,056,437 | 0.20% | Long | 2026-03-31 | |
| Fidelity Balanced Fund | — | 726,400 | $14,629,696 | 0.02% | Long | 2026-02-28 | |
| Columbia Small Cap Growth Fund | — | 638,423 | $12,857,839 | 0.40% | Long | 2026-02-28 | |
| ClearBridge Small Cap Growth Fund | — | 660,546 | $12,550,374 | 0.63% | Long | 2026-04-30 | |
| VIP Health Care Portfolio | — | 590,000 | $10,549,200 | 1.05% | Long | 2026-03-31 | |
| T. Rowe Price New Horizons Fund, Inc. | — | 588,972 | $10,530,819 | 0.08% | Long | 2026-03-31 | |
| Nuveen Quant Mid Cap Growth Fund | — | 527,890 | $10,029,910 | 1.47% | Long | 2026-04-30 | |
| Fidelity Advisor Mid Cap II Fund | — | 559,500 | $10,003,860 | 0.60% | Long | 2026-03-31 | |
| Champlain Small Company Fund | — | 556,000 | $9,941,280 | 0.97% | Long | 2026-03-31 | |
| ClearBridge Select Fund | — | 477,363 | $9,069,897 | 0.28% | Long | 2026-04-30 | |
| Fidelity Contrafund K6 | — | 500,750 | $8,953,410 | 0.03% | Long | 2026-03-31 | |
| JNL/T. Rowe Price Mid-Cap Growth Fund | — | 476,374 | $8,517,567 | 0.21% | Long | 2026-03-31 | |
| JNL/JPMorgan MidCap Growth Fund | — | 465,108 | $8,316,131 | 0.27% | Long | 2026-03-31 | |
| Fidelity Advisor Stock Selector Mid Cap Fund | — | 390,000 | $7,854,600 | 0.34% | Long | 2026-02-28 | |
| T. Rowe Price Integrated U.S. Small-Cap Growth Equity Fund | — | 426,121 | $7,619,043 | 0.09% | Long | 2026-03-31 | |
| LargeCap Growth Fund I | — | 383,792 | $7,292,048 | 0.12% | Long | 2026-04-30 | |
| Fidelity Growth Company K6 Fund | — | 336,115 | $6,769,356 | 0.03% | Long | 2026-02-28 | |
| JPMorgan Small Cap Growth Fund | — | 361,713 | $6,467,428 | 0.30% | Long | 2026-03-31 | |
| Fidelity Series Growth Company Fund | — | 308,141 | $6,205,960 | 0.03% | Long | 2026-02-28 | |
| iShares Russell Mid-Cap ETF | — | 346,891 | $6,202,411 | 0.01% | Long | 2026-03-31 | |
| Multi-Manager Large Cap Growth Strategies Fund | — | 343,823 | $6,147,555 | 0.13% | Long | 2026-03-31 | |
| T. Rowe Price Institutional Mid-Cap Equity Growth Fund | — | 316,926 | $5,666,637 | 0.21% | Long | 2026-03-31 | |
| iShares Russell Mid-Cap Growth ETF | — | 303,494 | $5,426,473 | 0.03% | Long | 2026-03-31 | |
| VIP Stock Selector Portfolio | — | 250,000 | $4,470,000 | 0.10% | Long | 2026-03-31 | |
| MassMutual Mid Cap Growth Fund | — | 249,038 | $4,452,799 | 0.16% | Long | 2026-03-31 | |
| Fidelity Advisor Multi-Asset Income Fund | — | 238,100 | $4,257,228 | 0.12% | Long | 2026-03-31 | |
| JPMorgan Mid Cap Equity Fund | — | 234,347 | $4,190,124 | 0.07% | Long | 2026-03-31 | |
| iShares Genomics Immunology and Healthcare ETF | — | 205,671 | $3,907,749 | 2.44% | Long | 2026-04-30 | |
| BlackRock Advantage Small Cap Core Fund | — | 193,829 | $3,903,716 | 0.09% | Long | 2026-02-27 | |
| Empower T. Rowe Price Mid Cap Growth Fund | — | 214,396 | $3,833,401 | 0.20% | Long | 2026-03-31 | |
| Fidelity Advisor Diversified Stock Fund | — | 213,500 | $3,817,380 | 0.10% | Long | 2026-03-31 | |
| Strategic Advisers U.S. Total Stock Fund | — | 185,239 | $3,730,713 | 0.00% | Long | 2026-02-28 | |
| MidCap Value Fund I | — | 196,272 | $3,729,168 | 0.15% | Long | 2026-04-30 | |
| Optimum Large Cap Growth Fund | — | 201,210 | $3,597,635 | 0.21% | Long | 2026-03-31 |
Showing 1–50 of 216 positions